Amphastar Pharmaceuticals, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $3.6M | $9.8M | $-2.8M | $-10.7M | $11.9M | $18.1M |
| Depreciation & Amortization | $6.4M | — | — | — | — | — |
| Depreciation | $13.0M | $12.2M | $11.3M | $12.5M | $11.2M | $9.7M |
| Amortization | $2.9M | $2.5M | $1.9M | $1.9M | $1.9M | $1.8M |
| Stock-Based Compensation | $17.1M | $15.1M | $12.8M | $9.3M | $6.1M | $6.7M |
| Net Cash from Operating Activities | $39.2M | $38.6M | $10.7M | $21.1M | $31.0M | $-1.7M |
| Investing Activities | ||||||
| Capital Expenditures | $35.1M | $21.4M | $16.0M | $20.5M | $17.6M | $23.1M |
| Business Acquisitions | — | $12.5M | — | $18.4M | — | — |
| Net Cash from Investing Activities | $-36.9M | $-39.5M | $-16.9M | — | — | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | $30.7M | $9.9M | $9.9M | $345.0K | $199.0K | $811.0K |
| Net Cash from Financing Activities | $-7.7M | $7.1M | $2.2M | — | — | — |
| Net Change in Cash | $-4.9M | $6.3M | $-1.8M | $14.2M | $3.4M | $-3.5M |
| Free Cash Flow | $4.1M | $17.2M | $-5.3M | $553.0K | $13.4M | $-24.8M |